PlainRecalls
FDA Drug Moderate Class II Terminated

FUCONPO CAPSULE, packaged in a 30-count bottle within a box, remaining labeling contains Chinese characters.

Reported: July 20, 2016 Initiated: April 20, 2016 #D-1347-2016

Product Description

FUCONPO CAPSULE, packaged in a 30-count bottle within a box, remaining labeling contains Chinese characters.

Reason for Recall

Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.

Details

Units Affected
unknown
Distribution
Nationwide and Puerto Rico
Location
Brooklyn, NY

Frequently Asked Questions

What product was recalled?
FUCONPO CAPSULE, packaged in a 30-count bottle within a box, remaining labeling contains Chinese characters.. Recalled by Murray International Trading Co., Inc.. Units affected: unknown.
Why was this product recalled?
Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 20, 2016. Severity: Moderate. Recall number: D-1347-2016.